tetano
Editor, Senior Moderator
Future Virol
. 2023 Jun;18(9):563-574.
doi: 10.2217/fvl-2022-0210. Epub 2023 Jul 13. Expression of TRIM56 gene in SARS-CoV-2 variants and its relationship with progression of COVID-19
Rezvan Tavakoli[SUP] 1 [/SUP], Pooneh Rahimi[SUP] 1 2 [/SUP], Mojtaba Hamidi-Fard[SUP] 1 2 [/SUP], Sana Eybpoosh[SUP] 3 [/SUP], Delaram Doroud[SUP] 4 [/SUP], Iraj Ahmadi[SUP] 5 [/SUP], Enayat Anvari[SUP] 5 [/SUP], Mohammadreza Aghasadeghi[SUP] 1 2 [/SUP], Abolfazl Fateh[SUP] 6 7 [/SUP]
Affiliations
Aim: The present study aimed to determine a correlation between differential TRIM56 expression levels and severe infections of COVID-19 between the Alpha, Delta and Omicron BA.5 variants.
Materials & methods: This study was performed on 330 COVID-19 patients, including 142 with severe and 188 with mild infections, as well as 160 healthy controls. The levels of TRIM56 gene expression were determined using a qPCR.
Results: TRIM56 gene showed significantly lower mRNA expression in the severe and mild groups compared with healthy individuals. Our finding indicated the high and low reduction of TRIM56 mRNA expression in Delta and Omicron BA.5 variant, respectively.
Conclusion: Further research is needed to characterize the impact of TRIM proteins on the severity of COVID-19.
Keywords: C-reactive protein; SARS-CoV-2; coronavirus disease 2019; mild infection; severe infection; tripartite motif containing 56; viral RNA load.
. 2023 Jun;18(9):563-574.
doi: 10.2217/fvl-2022-0210. Epub 2023 Jul 13. Expression of TRIM56 gene in SARS-CoV-2 variants and its relationship with progression of COVID-19
Rezvan Tavakoli[SUP] 1 [/SUP], Pooneh Rahimi[SUP] 1 2 [/SUP], Mojtaba Hamidi-Fard[SUP] 1 2 [/SUP], Sana Eybpoosh[SUP] 3 [/SUP], Delaram Doroud[SUP] 4 [/SUP], Iraj Ahmadi[SUP] 5 [/SUP], Enayat Anvari[SUP] 5 [/SUP], Mohammadreza Aghasadeghi[SUP] 1 2 [/SUP], Abolfazl Fateh[SUP] 6 7 [/SUP]
Affiliations
- PMID: 38051999
- PMCID: PMC10348059
- DOI: 10.2217/fvl-2022-0210
Aim: The present study aimed to determine a correlation between differential TRIM56 expression levels and severe infections of COVID-19 between the Alpha, Delta and Omicron BA.5 variants.
Materials & methods: This study was performed on 330 COVID-19 patients, including 142 with severe and 188 with mild infections, as well as 160 healthy controls. The levels of TRIM56 gene expression were determined using a qPCR.
Results: TRIM56 gene showed significantly lower mRNA expression in the severe and mild groups compared with healthy individuals. Our finding indicated the high and low reduction of TRIM56 mRNA expression in Delta and Omicron BA.5 variant, respectively.
Conclusion: Further research is needed to characterize the impact of TRIM proteins on the severity of COVID-19.
Keywords: C-reactive protein; SARS-CoV-2; coronavirus disease 2019; mild infection; severe infection; tripartite motif containing 56; viral RNA load.